Natural Product: NPC104170

Natural Product IDNPC104170
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
resokaempferol
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 5281611
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001615] Flavones
          • [CHEMONTID:0001136] Flavonols

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey OBWHQJYOOCRPST-UHFFFAOYSA-N
Standard InCHI InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)15-14(19)13(18)11-6-5-10(17)7-12(11)20-15/h1-7,16-17,19H
SMILES C1=CC(=CC=C1C2=C(C(=O)C3=C(O2)C=C(C=C3)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   270.05 Volume:   265.186
?
Van der Waals volume.
Dense:   1.018 LogP:   2.073
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.098
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.828
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   1.0 Rigid Bonds:   18.0
TPSA:   90.9
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   3.0 Rings:   3.0
Heavy Atoms:   5.0

MedChem Properties

QED Drug-Likeness Score:   0.632 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.179 Fsp3:   0.0
MCE-18:   17.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.784 Fluc inhibitor:   0.987
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.981
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.557
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.857 Promiscuous compounds:   0.915

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.621 MDCK Permeability:   -4.847
Pgp-inhibitor:   0.142 Pgp-substrate:   0.265
PAMPA:   0.774
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.038
20% Bioavailability (F20%):   0.317 30% Bioavailability (F30%):   0.781
50% Bioavailability (F50%):   0.986

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.738
Plasma Protein Binding (PPB):   96.659% Volume Distribution (VD):   -0.699
Fu: 3.325%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.869
OATP1B3 inhibitor:   0.989 BCRP inhibitor:   0.966
BSEP inhibitor:   0.83

ADMET: Metabolism

CYP1A2-inhibitor:   0.121 CYP1A2-substrate:   0.25
CYP2C19-inhibitor:   0.001 CYP2C19-substrate:   0.896
CYP2C9-inhibitor:   0.32 CYP2C9-substrate:   0.007
CYP2D6-inhibitor:   0.746 CYP2D6-substrate:   0.923
CYP3A4-inhibitor:   0.01 CYP3A4-substrate:   0.001
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.937
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  7.139 Half-life (T1/2):  1.493

ADMET: Toxicity

hERG Blockers:  0.105 hERG Blockers (10um):  0.508
Human Hepatotoxicity (H-HT):  0.403 Drug-induced Liver Injury (DILI):  0.673
AMES Toxicity:  0.552 Rat Oral Acute Toxicity:  0.454
Maximum Recommended Daily Dose:  0.742 Skin Sensitization:  0.629
Carcinogencity:  0.794 Eye Corrosion:  0.767
Eye Irritation:  0.998 Respiratory Toxicity:  0.639
Drug-induced Neurotoxicity:  0.108 Ototoxicity:  0.088
Hematotoxicity:  0.061 Drug-induced Nephrotoxicity:  0.026
Genotoxicity:  0.94 RPMI-8226 Immunitoxicity:  0.035
A549 Cytotoxicity:  0.203 Hek293 Cytotoxicity:  0.71
BCF:   1.218
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.751
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.404
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.071
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. DOI[10.1039/C8GC03728K]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[20929806]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[22544021]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[22851214]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[22909174]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[23727191]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[23864262]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[26062534]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[26358188]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[26488898]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[26951651]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[29077207]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[29096626]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[30061932]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[30496827]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[30684358]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[32830192]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[33195815]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. PMID[34824227]
NPO41850 A new engineered strain of Escherichia coli [n.a.] Strain Enterobacteriaceae Bacteria n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC104170 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8372 Intermediate Similarity NPC51443
0.8372 Intermediate Similarity NPC299379
0.7391 Intermediate Similarity NPC74881
0.7347 Intermediate Similarity NPC281207
0.6923 Remote Similarity NPC602125
0.6731 Remote Similarity NPC55205
0.6596 Remote Similarity NPC172262
0.6538 Remote Similarity NPC269652
0.6458 Remote Similarity NPC116775
0.6 Remote Similarity NPC195351
0.5962 Remote Similarity NPC136840
0.5918 Remote Similarity NPC93730
0.5686 Remote Similarity NPC70136
0.566 Remote Similarity NPC473042
0.56 Remote Similarity NPC606557
0.549 Remote Similarity NPC57601
0.5455 Remote Similarity NPC143799
0.5385 Remote Similarity NPC225731
0.5385 Remote Similarity NPC20791
0.5283 Remote Similarity NPC179271
0.5192 Remote Similarity NPC187432
0.5179 Remote Similarity NPC260895
0.5179 Remote Similarity NPC605146
0.5094 Remote Similarity NPC603556

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC104170 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5385 Remote Similarity NPD1512 Phase 3

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data